The Journal of Pediatrics
Volume 151, Issue 3 , Pages 255-259, September 2007

Primary Sclerosing Cholangitis in Childhood is Associated with Abnormalities in Cystic Fibrosis–Mediated Chloride Channel Function

  • Harpreet Pall, MD

      Affiliations

    • Division of Pediatric Gastroenterology, Children’s Hospital Boston, Harvard Medical School, Boston, MA
    • Corresponding Author InformationReprint requests: Dr Harpreet Pall, Children’s Hospital Boston, Division of Gastroenterology, 300 Longwood Avenue, Boston, MA 02115.
  • ,
  • Julian Zielenski, PhD

      Affiliations

    • Program in Genetics and Genomic Biology, The Hospital for Sick Children, Toronto, Ontario, Canada
  • ,
  • Maureen M. Jonas, MD

      Affiliations

    • Division of Pediatric Gastroenterology, Children’s Hospital Boston, Harvard Medical School, Boston, MA
  • ,
  • Deborah A. DaSilva, RN

      Affiliations

    • Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • ,
  • Kimberly M. Potvin

      Affiliations

    • Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • ,
  • Xiao-Wei Yuan, MSc

      Affiliations

    • Program in Genetics and Genomic Biology, The Hospital for Sick Children, Toronto, Ontario, Canada
  • ,
  • Qiuju Huang, MD

      Affiliations

    • Program in Genetics and Genomic Biology, The Hospital for Sick Children, Toronto, Ontario, Canada
  • ,
  • Steven D. Freedman, MD, PhD

      Affiliations

    • Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

Received 5 November 2006; received in revised form 12 February 2007; accepted 30 March 2007. published online 28 July 2007.

Objective

To determine whether primary sclerosing cholangitis (PSC) in childhood is associated with abnormalities in cystic fibrosis transmembrane conductance regulator (CFTR).

Study design

Subjects with PSC diagnosed in childhood (n = 20) were recruited from Children’s Hospital. Subjects had testing with sweat chloride concentration, nasal transmembrane potential difference, and extensive genetic analysis of the CFTR gene. Disease control subjects consisted of 14 patients with inflammatory bowel disease alone and no liver disease. t Tests were performed to determine statistical significance.

Results

In the PSC group, CFTR chloride channel function (ΔChloride free + isoproterenol) was markedly diminished at −8.6 ± 8.2 mV (reference range: −24.6 ± 10.4 mV). In contrast, disease control subjects had normal function, at −17.8 ± 9.7 mV (P = .008). Sweat chloride concentration in subjects with PSC was greater than in disease control subjects (20.8 ± 3.4 mmol/L vs 12.0 ± 1.6 mmol/L, P = .045). Comprehensive CFTR genotyping revealed that 5 of 19 (26.3%) subjects with PSC had a CFTR mutation or variant, compared with 6 of 14 (42.9%) disease control subjects.

Conclusions

There is a high prevalence of CFTR-mediated ion transport dysfunction in subjects with childhood PSC.

Abbreviations: CF, Cystic fibrosis, CFTR, Cystic fibrosis transmembrane conductance regulator, ERCP, Endoscopic retrograde cholangiopancreatography, IBD, Inflammatory bowel disease, MRCP, Magnetic resonance cholangiopancreatography, NTPD, Nasal transmembrane potential difference, PPAR, Peroxisome proliferator activated receptor, PSC, Primary sclerosing cholangitis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the Thrasher Research Fund (grant 02820-4) and The General Clinical Research Centers at Children’s Hospital Boston (NIH M01 RR02172) and The Beth Israel Deaconess Medical Center (NIH M01 RR01032). Dr Pall was supported in part by the Harvard/MIT Clinical Investigator Training Program. This project was also partially funded by Genome Canada through the Ontario Genomics Institute as per research agreement 2004-OGI-3-05. The study sponsors did not have a role in the study design, data analysis, or preparation of the manuscript.

PII: S0022-3476(07)00330-7

doi:10.1016/j.jpeds.2007.03.062

Refers to article:

  • What is the Role of Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Primary Sclerosing Cholangitis?

    Dennis D. Black
    The Journal of Pediatrics September 2007 (Vol. 151, Issue 3, Pages 230-232)

The Journal of Pediatrics
Volume 151, Issue 3 , Pages 255-259, September 2007